ReP USP - Resultado da busca

Trabalho de evento-resumo periodico
Methotrexate associated with nanoparticles decreases NLRC4 inflammasome expression in infarcted rat hearts (2023)
Gatto, Mariana ; Mota, Gustavo Augusto Ferreira ; Borim, Patrícia Aparecida ; Santos, A. C. C; Pagan, Luana Urbano ; Souza, L. M; Rodrigues, E. A; Silva, R. C. F; Oliveira, J. P. G; Meirelles, A. L. B; Brosler, Jessica Yumi ; Maranhão, Raul Cavalcante ; Zornoff, Leonardo Antônio Mamede ; Okoshi, Katashi ; Okoshi, Marina Politi
Source: European Heart Journal. Conference titles: European Society of Cardiology Congress/ESC. Unidade: FCF
Subjects: METOTREXATO, NANOPARTÍCULAS
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
GATTO, Mariana et al. Methotrexate associated with nanoparticles decreases NLRC4 inflammasome expression in infarcted rat hearts. European Heart Journal. Oxford: Faculdade de Ciências Farmacêuticas, Universidade de São Paulo. Disponível em: https://academic.oup.com/eurheartj/article/44/Supplement_2/ehad655.3097/7390939. Acesso em: 10 nov. 2024. , 2023
APA
Gatto, M., Mota, G. A. F., Borim, P. A., Santos, A. C. C., Pagan, L. U., Souza, L. M., et al. (2023). Methotrexate associated with nanoparticles decreases NLRC4 inflammasome expression in infarcted rat hearts. European Heart Journal. Oxford: Faculdade de Ciências Farmacêuticas, Universidade de São Paulo. Recuperado de https://academic.oup.com/eurheartj/article/44/Supplement_2/ehad655.3097/7390939
NLM
Gatto M, Mota GAF, Borim PA, Santos ACC, Pagan LU, Souza LM, Rodrigues EA, Silva RCF, Oliveira JPG, Meirelles ALB, Brosler JY, Maranhão RC, Zornoff LAM, Okoshi K, Okoshi MP. Methotrexate associated with nanoparticles decreases NLRC4 inflammasome expression in infarcted rat hearts [Internet]. European Heart Journal. 2023 ; 44( p.):[citado 2024 nov. 10 ] Available from: https://academic.oup.com/eurheartj/article/44/Supplement_2/ehad655.3097/7390939
Vancouver
Gatto M, Mota GAF, Borim PA, Santos ACC, Pagan LU, Souza LM, Rodrigues EA, Silva RCF, Oliveira JPG, Meirelles ALB, Brosler JY, Maranhão RC, Zornoff LAM, Okoshi K, Okoshi MP. Methotrexate associated with nanoparticles decreases NLRC4 inflammasome expression in infarcted rat hearts [Internet]. European Heart Journal. 2023 ; 44( p.):[citado 2024 nov. 10 ] Available from: https://academic.oup.com/eurheartj/article/44/Supplement_2/ehad655.3097/7390939
Trabalho de evento-resumo periodico
HDL-cholesterol dysfunction and inflammation in patients with genotypes associated with different responses to dalcetrapib (2018)
Franci, André; Barbosa, Carlos José Dornas Gonçalves; Pereira, Alexandre da Costa; Dalcoquio, Talia; Barreiros, Renata de Souza; Baracioli, Luciano Moreira; Santos, Paulo Caleb Junior de Lima; Freitas, Fatima Rodrigues de; Ramires, José Antônio Franchini; Kalil Filho, Roberto; Maranhão, Raul Cavalcante
Source: European Heart Journal. Conference titles: European Society of Cardiology Congress/ESC. Unidades: FM, FCF
Subjects: COLESTEROL, GENÓTIPOS, INFLAMAÇÃO
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
FRANCI, André et al. HDL-cholesterol dysfunction and inflammation in patients with genotypes associated with different responses to dalcetrapib. European Heart Journal. Oxford: Faculdade de Medicina, Universidade de São Paulo. . Acesso em: 10 nov. 2024. , 2018
APA
Franci, A., Barbosa, C. J. D. G., Pereira, A. da C., Dalcoquio, T., Barreiros, R. de S., Baracioli, L. M., et al. (2018). HDL-cholesterol dysfunction and inflammation in patients with genotypes associated with different responses to dalcetrapib. European Heart Journal. Oxford: Faculdade de Medicina, Universidade de São Paulo.
NLM
Franci A, Barbosa CJDG, Pereira A da C, Dalcoquio T, Barreiros R de S, Baracioli LM, Santos PCJ de L, Freitas FR de, Ramires JAF, Kalil Filho R, Maranhão RC. HDL-cholesterol dysfunction and inflammation in patients with genotypes associated with different responses to dalcetrapib. European Heart Journal. 2018 ; 39 1212 res. P5729.[citado 2024 nov. 10 ]
Vancouver
Franci A, Barbosa CJDG, Pereira A da C, Dalcoquio T, Barreiros R de S, Baracioli LM, Santos PCJ de L, Freitas FR de, Ramires JAF, Kalil Filho R, Maranhão RC. HDL-cholesterol dysfunction and inflammation in patients with genotypes associated with different responses to dalcetrapib. European Heart Journal. 2018 ; 39 1212 res. P5729.[citado 2024 nov. 10 ]
Trabalho de evento-resumo periodico
Lipid core nanoparticles as vehicle for docetaxel reduces atherosclerotic lesion, inflammation, cell death and proliferation in an atherosclerosis rabbit model (2018)
Meneghini, Bianca Correa; Tavares, Elaine Rufo; Guido, Maria Carolina; Tavoni, Thauany Martins; Kalil Filho, Roberto; Maranhão, Raul Cavalcante
Source: European Heart Journal. Conference titles: European Society of Cardiology Congress/ESC. Unidades: FM, FCF
Subjects: LIPÍDEOS, NANOPARTÍCULAS, ARTERIOSCLEROSE
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
MENEGHINI, Bianca Correa et al. Lipid core nanoparticles as vehicle for docetaxel reduces atherosclerotic lesion, inflammation, cell death and proliferation in an atherosclerosis rabbit model. European Heart Journal. Oxford: Faculdade de Medicina, Universidade de São Paulo. . Acesso em: 10 nov. 2024. , 2018
APA
Meneghini, B. C., Tavares, E. R., Guido, M. C., Tavoni, T. M., Kalil Filho, R., & Maranhão, R. C. (2018). Lipid core nanoparticles as vehicle for docetaxel reduces atherosclerotic lesion, inflammation, cell death and proliferation in an atherosclerosis rabbit model. European Heart Journal. Oxford: Faculdade de Medicina, Universidade de São Paulo.
NLM
Meneghini BC, Tavares ER, Guido MC, Tavoni TM, Kalil Filho R, Maranhão RC. Lipid core nanoparticles as vehicle for docetaxel reduces atherosclerotic lesion, inflammation, cell death and proliferation in an atherosclerosis rabbit model. European Heart Journal. 2018 ; 39 804 res. P3792.[citado 2024 nov. 10 ]
Vancouver
Meneghini BC, Tavares ER, Guido MC, Tavoni TM, Kalil Filho R, Maranhão RC. Lipid core nanoparticles as vehicle for docetaxel reduces atherosclerotic lesion, inflammation, cell death and proliferation in an atherosclerosis rabbit model. European Heart Journal. 2018 ; 39 804 res. P3792.[citado 2024 nov. 10 ]

USP Schools

ReP

Filtros

Authors

Subjects